Abstract
The article by Farjah and colleagues [1] is very interesting, and two aspects are relevant; on one hand, only 9% of patients affected by T4 nonsmall cell lung cancer (NSCLC) are eligible for lung resection; on the other, survival of a carefully selected group of patients may be very promising (5 yrs > 40%).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
